Market Overview

Benzinga's Top Pre-Market Gainers

Related LXRX
Lexicon Announces A Publication In The American Diabetes Association's Journal, Diabetes Care
Benzinga's Top Downgrades
Related ARIA
GNC, Southern Copper And Others Insiders Have Been Buying
ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Israel

Lexicon Pharmaceuticals (NASDAQ: LXRX) surged 10.70% to $2.07 in the pre-market session. Lexicon Pharmaceuticals reported that it has received "Fast Track" status from the FDA for the development of LX1033.

Ariad Pharmaceuticals (NASDAQ: ARIA) added 3.48% to $19.59 in the pre-market session. ARIAD Pharmaceuticals reported that the FDA has granted accelerated approval of Iclusig™ (ponatinib).

American Capital Agency (NASDAQ: AGNC) moved up 2.85% to $31.06 in the pre-market session. American Capital Agency declared a Q4 cash dividend of $1.25 per common share.

Sprint Nextel (NYSE: S) soared 2.16% to $5.67 in the pre-market trading. Sprint will acquire the approximately 50% stake in Clearwire (NASDAQ: CLWR) it does not currently own for $2.97 per share.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (AGNC + ARIA)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional